EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder

Jennifer B Levin iD, Melissa DelBello, Avani C Modi, Farren Briggs, Larry F Forthun, Molly McVoy, Joy Yala, Raechel Cooley, Jessica Black, Carla Conroy, Martha Sajatovic iD

Bipolar Disorders · 2024

DOI: 10.1111/bdi.13489 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Bipolar Disorders, 2024. Verfasst von Jennifer B Levin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Medication Adherence. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NCATS NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Few studies have addressed medication adherence in adolescents and young adults (AYAs) with bipolar disorder (BD). This 6‐month prospective randomized‐controlled trial (RCT) tested customized adherence enhancement for adolescents and young adults (CAE‐AYA), a behavioral intervention for AYAs versus enhanced treatment as usual (ETAU).

Methods

Inclusion criteria were AYAs age 13–21 with BD type I or II with suboptimal adherence defined as missing ≥20% of medications. Assessments were conducted at Screening, Baseline, and weeks 8, 12 and 24. Primary outcome was past 7 day self‐reported Tablets Routine Questionnaire (TRQ) validated by electronic pillbox monitoring (SimpleMed). Symptom measures included the Hamilton Depression Rating Scale (HAM‐D) and Young Mania Rating Scale (YMRS).

Results

The mean sample age ( N = 36) was 19.1 years (SD = 2.0); 66.7% ( N = 24) female, BD Type I (81%). The mean missed medication on TRQ for the total sample was 35.4% (SD = 28.8) at screening and 30.4% (SD = 30.5) at baseline. Both CAE‐AYA and ETAU improved on TRQ from screening to baseline. Baseline mean missed medication using SimpleMed was 51.6% (SD = 38.5). Baseline HAM‐D and YMRS means were 7.1 (SD = 4.7) and 6.0 (SD = 7.3), respectively. Attrition rate at week 24 was 36%. Baseline to 24‐week change on TRQ, adjusting for age, gender, educational level, living situation, family history, race, and ethnicity, showed improvement favoring CAE‐AYA versus ETAU of 15%. SimpleMed interpretation was limited due to substantial missing data. There was a significant reduction in depression favoring CAE‐AYA.

Conclusions

CAE‐AYA may improve adherence in AYAs with BD, although conclusions need to be made cautiously given study limitations. Clinical Trials Registration ClinicalTrials.gov identifier: NCT04348604.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMedication AdherenceHumansFemaleMaleAdolescentYoung AdultPsychiatric Status Rating ScalesProspective StudiesPatient Education as TopicTreatment Outcome

Stichwörter der Autor:innen

adherenceadolescents and young adultsbipolar disordermood stabilizer

Autor:innen und Institutionen

  • Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • College of Medicine, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Jennifer B Levin, Martha Sajatovic

Förderung

  • NIMH NIH HHS
  • NCATS NIH HHS
  • National Institute of Mental Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Levin, J. B., DelBello, M., Modi, A. C., Briggs, F., Forthun, L. F., McVoy, M., Yala, J., Cooley, R., Black, J., Conroy, C., & Sajatovic, M. (2024). A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders. https://doi.org/10.1111/bdi.13489

Vancouver

Levin JB, DelBello M, Modi AC, Briggs F, Forthun LF, McVoy M, et al. A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders. 2024. doi:10.1111/bdi.13489

BibTeX
@article{Levin2024,
  author = {Levin, Jennifer B and DelBello, Melissa and Modi, Avani C and Briggs, Farren and Forthun, Larry F and McVoy, Molly and Yala, Joy and Cooley, Raechel and Black, Jessica and Conroy, Carla and Sajatovic, Martha},
  title = {A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder},
  journal = {Bipolar Disorders},
  year = {2024},
  doi = {10.1111/bdi.13489}
}
Kostenlos starten →